| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.47 | $44.01 (0%) | 🛒 Add to cart |
| 60 | $1.15 | $88.03 $69.02 (22%) | 🛒 Add to cart |
| 90 | $1.06 | $132.04 $95.03 (28%) | 🛒 Add to cart |
| 120 | $1.00 | $176.06 $120.04 (32%) | 🛒 Add to cart |
| 180 | $0.94 | $264.09 $169.06 (36%) | 🛒 Add to cart |
| 270 | $0.91 | $396.13 $246.08 (38%) | 🛒 Add to cart |
| 360 | $0.89
Best per pill | $528.18 $321.11 (39%) | 🛒 Add to cart |
Synonyms
| |||
Similar products
More info:
paroxetine
Paroxetine is a selective serotonin reuptake inhibitor (SSRI) antidepressant medication, not a dietary supplement or medical device. It’s prescribed primarily for major depressive disorder, various anxiety disorders, and other psychiatric conditions. As a prescription medication, paroxetine requires careful medical supervision due to its potent effects on neurotransmitter systems and potential for significant side effects and withdrawal symptoms. 1. Introduction: What is Paroxetine? Its Role in Modern Medicine Paroxetine represents one of the most widely prescribed antidepressants in the SSRI class, with decades of clinical use supporting its efficacy across multiple psychiatric conditions.
Abilify: Dopamine System Stabilization for Multiple Psychiatric Conditions - Evidence-Based Review
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in psychopharmacology as a second-generation antipsychotic medication. Unlike earlier antipsychotics that primarily acted through dopamine D2 receptor antagonism, aripiprazole functions as a partial dopamine agonist - a novel mechanism that provides both agonist activity when dopamine levels are low and antagonist effects when dopamine is excessive. This unique pharmacological profile has positioned it as a versatile agent in managing various psychiatric conditions including schizophrenia, bipolar disorder, major depressive disorder as adjunctive therapy, and irritability associated with autistic disorder.
Amitriptyline: Multimodal Relief for Chronic Pain and Depression - Evidence-Based Review
Amitriptyline is a tricyclic antidepressant (TCA) that has been a cornerstone in psychiatric and pain management for decades. Initially developed for depression, its utility has expanded significantly due to its multifaceted pharmacological profile. It’s not just an antidepressant—it’s a versatile agent for chronic pain, migraine prophylaxis, and various off-label uses, making it a staple in many clinicians’ arsenals. The drug’s enduring relevance stems from its robust efficacy, affordability, and the depth of real-world experience supporting its use, despite the emergence of newer agents.
aricept
Donepezil hydrochloride, marketed under the brand name Aricept, is a centrally acting, reversible acetylcholinesterase inhibitor. It’s specifically indicated for the symptomatic treatment of mild to moderate Alzheimer’s disease. This isn’t a dietary supplement or a device; it’s a prescription pharmaceutical that directly targets the cholinergic deficit widely recognized as a core pathological feature in Alzheimer’s dementia. Its development was a significant step forward in the 1990s, offering the first real pharmacological hope for slowing the cognitive decline in a condition that had been largely untreatable.
Bromhexine: Effective Mucus Clearance for Respiratory Conditions - Evidence-Based Review
Bromhexine hydrochloride is a well-established mucolytic agent, a derivative of the vasicine alkaloid from Adhatoda vasica, used clinically since the 1960s. It functions as a secretolytic and secretomotor drug, facilitating the clearance of viscous, tenacious mucus from the respiratory tract. This monograph provides a comprehensive, evidence-based review of its pharmacology, clinical applications, and practical use. 1. Introduction: What is Bromhexine? Its Role in Modern Medicine Bromhexine is a synthetic derivative of the plant alkaloid vasicine, developed as a pharmaceutical agent to address abnormal mucus viscosity and impaired mucociliary clearance.
Bupron SR: Sustained Mood Stabilization and Smoking Cessation - Evidence-Based Review
Bupron SR is a sustained-release formulation of bupropion hydrochloride, primarily indicated as an antidepressant and smoking cessation aid. This monograph examines the extended-release mechanism that provides stable plasma concentrations over 24 hours, distinguishing it from immediate-release formulations through its polymer-based matrix system. The SR technology represents a significant advancement in maintaining therapeutic levels while minimizing peak-trough fluctuations that often cause side effects. 1. Introduction: What is Bupron SR? Its Role in Modern Medicine Bupron SR belongs to the aminoketone class of antidepressants, chemically unrelated to SSRIs or tricyclics.
bystolic
Bystolic represents one of those interesting cases where a beta-blocker managed to distinguish itself in a crowded therapeutic class. Known generically as nebivolol, this medication occupies a unique position in cardiovascular management due to its distinctive pharmacological profile that combines beta-1 selectivity with nitric oxide-mediated vasodilation. Unlike traditional beta-blockers that often cause peripheral vasoconstriction and cold extremities, Bystolic offers hemodynamic benefits that make it particularly valuable in hypertension management. Bystolic: Advanced Blood Pressure Control with Vasodilatory Benefits 1.
Celexa: Effective Symptom Relief for Major Depressive Disorder - Evidence-Based Review
Celexa, known generically as citalopram hydrobromide, is a selective serotonin reuptake inhibitor (SSRI) antidepressant medication approved by the FDA for the treatment of major depressive disorder (MDD) in adults. It functions by increasing serotonin levels in the brain, which helps improve mood, sleep, appetite, and energy level. Celexa is one of the most widely prescribed antidepressants globally due to its efficacy and relatively favorable side effect profile compared to older antidepressants.
clomid
Clomiphene citrate, commonly known by its brand name Clomid, represents one of the most foundational and extensively studied oral ovulation induction agents in reproductive medicine. As a selective estrogen receptor modulator (SERM), its primary mechanism involves blocking estrogen receptors at the hypothalamic level, which tricks the body into perceiving low estrogen levels. This prompts increased gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus, subsequently stimulating the pituitary gland to release more follicle-stimulating hormone (FSH) and luteinizing hormone (LH).